AstraZeneca gets partial immunity in low-cost EU vaccine deal, Reuters reports
Unexpected side-effects after a drug has regulatory approval are rare
AstraZeneca, under fire for vaccine safety, releases trial blueprints
Experts are concerned that the company has not been more forthcoming about two more participants who became seriously ill
Clinical trials for the AstraZeneca vaccine resume
It was now safe for the tests to proceed, the company announced on Saturday